GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ARAV
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

FAQ

What is the symbol for Aravive Inc. Stock and on which exchange is it traded?
The symbol for Aravive Inc. is ARAV and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Aravive Inc. Stock?
Aravive Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Aravive Inc. Stock?
Aravive Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Aravive Inc. Stock.

What's the current price of Aravive Inc. Stock?
As of the end of day on the 2024-04-19, the price of an Aravive Inc. (ARAV) share was $0.0401.

What is the 52-week high and low for Aravive Inc. Stock?
The 52-week high for Aravive Inc. Stock is $1.97 and the 52-week low is $0.0401.

What is the market capitalization of Aravive Inc. Stock?
As of the 2024-04-19, the market capitalization of Aravive Inc. is 2.95M.

When is the next earnings date for Aravive Inc.?
The upcoming earnings date for Aravive Inc. is May 08, 2024.
Click to get the best stock tips daily for free!

About Aravive Inc.

Aravive. Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of platinum- resistant recurrent ovarian cancer; and in Phase Ib/II clinical trial for the treatment of clea... ARAV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT